Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDOne: Low Sodium PD Solution in Hypertensive Patients
NCT00794326Phase 3Completed
- Sponsor
- Fresenius Medical Care
- Start
- Oct 2008
- Primary completion
- Dec 2014
- Modality
- SOLN (Solution)
- Countries
- 5
01
Overview
Phase 3, randomised, single-blind trial of PDsol 12 in hypertension (HTN) (2 arms), sponsored by Fresenius Medical Care. Primary endpoint: Ambulatory 24 h mean systolic blood pressure measurement and drug doses management at 8 weeks. Started Oct 2008; status: completed.
02
Drugs
PDsol 12
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00794326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794326.